PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
58.09
Similar ESG score to TGTX's 60.33. Bruce Berkowitz would investigate if industry ESG norms adequately address regulatory risks.
56.82
Environmental score 90-95% of TGTX's 61.09. Bill Ackman would demand clear environmental improvement catalysts.
57.54
Social score 90-95% of TGTX's 63.10. Bill Ackman would demand clear social improvement catalysts.
59.92
Governance score 1.1-1.2x TGTX's 56.81. Guy Spier would verify if superior governance translates to better capital allocation and strategic execution.